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Message from Amy K. Starosciak, Ph.D. 
Director of Outcomes Research, Center for Research 
H appy holidays and happy New Year to the BHSF Research group!  In this issue we look back over the year and contemplate the impressive changes that  our research departments have undertaken to ensure that 
our patients and staff remain safe while participating in and 
conducting clinical research as well as celebrate some of the 
successes we have seen throughout the year. 
It has been a year since the launch 
of the system-wide Research 
Matters newsletter in December 
2019.  On the right, here are some 
statistics from the first volume.  
Thanks to the editorial team for their 
dedication to this effort! 
As we look at what is to come for 
Research Matters, we are seeking 
new members to our editorial 
team — an Associate Editor and 
Editor-in-Chief.  As some of you 
may know, we bid farewell to Noah 
Zanville, Ph.D., RN, who left Baptist 
Health to become the Nurse 
Scientist Scholar at Mission Health 
in Asheville, NC overseeing their nursing research program.  Also, I 
would like to give the Editor-in-Chief opportunity to someone who is 
passionate about research and connecting with the greater BHSF 
research community.  If you are interested in joining the editorial 
team, please contact me at amyst@baptisthealth.net.   Read back 
issues of the newsletter on the Scholarly Commons. 
It also has been one year since the launch of the BHSF Research 
Operations Lunch & Learn, that started in-person in January 2020 
and has been taking place remotely since April.  Check out page 5 for 
some stats on the Lunch & Learn and page 7 for the 2021 schedule.   
Finally, with the COVID-19 pandemic still looming over us, we see 
hope in research and hope with the vaccine.  The pandemic led to 
some extraordinary and innovative changes in our research 
departments, so check out pages 3 and 4 to see what MCVI and 
Boca Raton research programs have implemented for now and 
the future.  With that, I wish everyone a happy and healthy New Year.  
Stay safe out there!  And continue doing exceptional work. 




with an opinion.” 
—W. Edwards Deming— 
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New Staff Updates 
Catherina Chang-
Martinez, Ph.D., MSN, 
RN, ARNP 
Nurse Scientist 
Nursing & Health Sciences 
Claire P. Valdes, 
BSN, RN 
Clinical Data Analyst 
Miami Neuroscience 
Institute Research 
Spotlight on Boca Raton Regional Hospital's Research Programs 
MARCUS NEUROSCIENCE INSTITUTE 
R esearch at the Marcus Neuroscience Institute (MNI) at Boca Raton Regional Hospital integrates the practices of Neurology, Neurosurgery, and Neuro-oncology. 
Currently the trial portfolio includes research from pharmaceutical industry for Migraine, 
Parkinson’s disease, Multiple Sclerosis, and Orthostatic Hypotension. Moreover, MNI 
participates in clinical trials through the NIH StrokeNet, as well as collaborates with Duke 
University, University of Florida, Florida Atlantic University, and Scripps Research. 
In addition to stroke and brain tumor trials, MNI offers a trial that evaluates cord tissue 
derived mesenchymal stem cells for treatment of acute respiratory syndrome (ARDS) in 
patients with COVID-19 infection. There have been two patients enrolled at MNI and 
overall enrollment of 10 patients through out all the participating sites. The institute is 
planning to open a research laboratory in 2021 to continue advancing stem cell research 
and expand its use to areas like stroke.  
A highly trained and experienced group of physicians brings years of clinical and 
research experience to the Institute. The medical team consists of eight neurologists, 
including a neuro-oncologist and a neuro-intensivist, and five neurosurgeons.  The 
institute Senior Research Nurse and the research administrative team work very closely 
with the clinical staff to enroll patients in clinical trials and evaluate new research 
opportunities to offer to our patients. —Stephanie A. Boodram, Research Data Analyst, 
Office of Research Administration & Lynn Cancer Institute 
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A t the Miami Cardiac & Vascular Institute (MCVI), the COVID-19 pandemic changes have accelerated an innovative transformation for the conduct of research trials. Here, we share our 
experience hoping to offer suggestions to navigate these changes for successful outcomes.  
Our sponsors, investigators, clinical research professionals, clinical trial coordinators, managers, 
and nurses report positive experiences with these COVID-related adjustments. These measures are 
aiming to help reduce the spread of COVID-19 and require the integration and collaboration of sites, 
sponsors, and other BHSF departments to reimagine how to safely conduct clinical trials in a remote 
and technology-based environment.  
This was no small task, as adopting new technology requires administrative, regulatory, and process 
changes. These changes also are part of a sustainable model so we do feel some of the measures 
we have introduced in 2020 to mitigate COVID-19 disruptions are here to stay. 
 Removed unnecessary site visits. Restrictions implemented for outside vendors, monitors, 
or clinical research associates. 
 Established several new partnerships to study COVID in close collaboration with the 
David Geffen School of Medicine at UCLA and the Icahn School of Medicine at Mount Sinai in 
New York City. We have engaged in 5, very innovative and distinctive COVID trials, including 
filing of our own MCVI formal IND application with the FDA to study the effects of COVID in 
the myocardium and all open studies are actively enrolling patients.  
 Adopted remote monitoring, remote review/verification of research participant data, remote 
site qualification, and remote site initiation visits.  
 Reduced in-person participant interaction for non-clinical related tasks. 
 Incorporated phone calls and remote checks for participants. 
 Protect patient and staff with changes such as: remote consents, when possible conducting 
remote study visits, and streamlining the clinical trial participation process. 
 Created COVID Standard Operational Procedures and new policies for addressing research 
activities during potential similar emergencies at our workplace.  
 Adopted routine inspection suspension as determined by the FDA. 
 Remote document creation, management, and collection. 
 Continued strict study oversight and compliance adherence. 
 Allowed offsite work when possible and in accordance with BHSF policies. 
 Began conducting all committee meetings virtually. 
We do hope these suggestions help, we do feel that now more than ever is crucial for all BHSF 
research Centers of Excellence to communicate with each other and share projects, collaborations 
and recommendations for keeping sites running in accordance with the highest scientific and 
regulatory standards. All ideas and tips on virtual check-ins with patients, how to incorporate at-
home follow up visits or even suggestions on where to cut expenses to save money, working 
together could help find ways to make it through this pandemic. 
For MCVI, the strength has been the consistently solid team structure and the intensely cohesive 
nature of our group. MCVI research is very unified; that has made the difference. 
—Raul Herrera, M.D., Director of  Research and Outcomes, Miami Cardiac & Vascular Institute 
EFFECTS OF COVID-19 
 
How the Pandemic Accelerated the Transformation of MCVI Research  
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C 
onducting clinical trials research is 
always a frenetic endeavor.  This year 
we added a wholly unexpected variable 
to this complex equation when the COVID 
pandemic hit our area.  Some industries had 
no choice but to put operations on hold and 
hunker down to maintain the safety of their 
employees and the public.  Our choice was 
clear; we had to continue providing access 
to clinical trials that were opened before 
COVID for the continuity of care for our 
patients.  To maintain that continuity, we had 
to adapt our processes to ensure the safety 
of our research staff and the patients on our 
trials.  The research community is fairly close 
knit and we become very familiar with our 
clinical trial sponsor representatives as well 
as our regulatory contacts.  These groups 
came together to ensure the continued 
access to clinical trials that is so critical for 
our patients’ care. 
At Boca Raton Regional Hospital, these 
changes included: 
 Implementing sponsors’ COVID-specific 
protocol changes to minimize disruptions 
in trial conduct including remote patient 
visits wherever possible.  This change 
complemented our institution’s 
restrictions on visits to minimize potential 
patient exposure. 
 Regulatory bodies (e.g., IRBs) allowing 
for quick submission and turnaround of 
protocol and site amendments to 
accommodate institutional, local, state 
and federal restrictions.  These changes 
allowed fluidity to implement changes to 
maintain continuity of clinical trials. 
 Innovation by our study coordinators to 
ensure the patient experience and care 
was minimally impacted.  For example, 
one of the toughest changes came with 
restricting patients from having their 
family members accompany them as 
normally would have been the case due 
to COVID restrictions.  The coordinators 
adapted to the change and conducted the 
patient visits with the family member on 
video call to make the visit as close to 
“normal” as possible. 
—Ileana Vargas, Research Regulatory 
Specialist, Office of Research Administration 
& Lynn Cancer Institute 
EFFECTS OF COVID-19 
 
Longer Term Effects on Research at Boca Raton Regional Hospital 
Image from BHSF Care on Demand 
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2020 Attendees Survey Dashboard 
BHSF RESEARCH LUNCH & LEARN 
W e successfully completed a year of Research Lunch & Learns, of which April-December were virtual.  In April, we converted to REDCap to document attendance and survey attendees to ensure that we were providing interesting and 
useful information for to our staff.  A total of 290 people attended in 2020 for an average of 
24 people/session.  There were 80 unique attendees from Boca Raton Regional Hospital, 
Center for Research, IRB, MCI Office of Clinical Trials Office, MCI Clinical Operations 
Support, MCI Protocol Support Laboratory and Biorepository, MCVI Research & Outcomes, 
MNI Research (South), MOSMI/UHZ Research, and Nursing & Health Science Research. 
The topics and order were developed based on a Needs Assessment Survey sent to 
research operations and regulatory staff in December 2019.  Respondents selected the top 
three topics they were interested in.  However, with the COVID-19 pandemic, three relevant 
topics were selected for April through June, and resumed with the original order in July.  The 
dashboard from the attendee survey is provided below.  A new Needs Assessment Survey 
was sent in December 2020 with added topics and the new set of topics for 2021 can be 
found on Page 7. 
—Amy K. Starosciak, Ph.D., Director of Outcomes Research, Center for Research 
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Explore our new publications! 
New Article Alcove 
*Alvarez R, ^Chinea AV, ^Braley AE, ^Majid S, Patel K, Segui D, Starosciak AK, 
Gonzalez-Arias S (2021) Cortical screw fixation using CT-navigation coupled with real
-time electrophysiological monitoring of individual screw placement for unstable 
degenerative lumbar spondylolisthesis.   Interdisc Neurosurg 24:101051.  Find it 
here! (*Current FIU Medical Student, ^Former FIU Medical Student) 
Appunni S, Rubens M, Ramamoorthy V, Anand V, Khandelwal M, Saxena A, 
McGranaghan P, Odia Y, Kotecha R, Sharma A (2021) Lumican, pro-tumorigenic or 
anti-tumorigenic: A conundrum.  Clin Chim Acta 514: 1-7.  Find it here! 
Balduzzi A, van der Heijde N, Alsedi A...Asburn HJ, et al. (in press) Risk factors and 
outcomes of conversion inminimally invasive distal pancreatectomy: A systematic 
review.  Lagenbecks Arch Surg  Find it here! 
Huang J & Mehta M (in press) Can proton therapy reduce radiation-related 
lymphopenia in glioblastoma? Neuro Oncol  Find it here! 
Kittipibul V, Singh H, Flowers R, Chaparro S (2020) The utility of CardioMEMS in left 
ventricular assist device patients with gastrointestinal bleeding.  J Cardiol Cases 
22:276-279.  Find it here! 
Kotecha R,  Dea N, Detsky JS, Sahgal A (2020) Management of recurrent 
or progressive metastases : Reirradiation techniques and surgical 
principles.  Neurooncol Pract 7(Suppl 1):i45-i53.  Find it here! 
Mayock DE, Xies Z, Comstock BA...on behalf of the PENUT Trial 
consortium (includes Perez JE, Diaz Barbosa M, Bombino S) (2020) High-
dose erythropoietin in extremely low gestational age neonates does not 
alter risk of retinopathy of prematurity.  Neonatology 28: 1-8.  Find it 
here! 
Mekhail N, Deer TR, Kramer J,...Levy RM (2020) Paresthesia-free dorsal 
root ganglion stimulation: An ACCURATE study sun-analysis.  
Neuromodulation 23(2): 185-195.  Find it here! 
Mossahebi S, Sabouri P, Chen H, et al. (2020) Initial validation of proton 
dose calculations on SPR images from DECT in treatment planning system.  
Int J Part Ther 7(2):51-61.  Find it here! 
Oni E, Ogunmoroti O, Allen N...Veledar E, Nassir K (in press)  Life’s Simple 
7 and non-alcholohic fatty liver disease: The multi-ethnic study of 
atherosclerosis.  Am J Med   Find it here! 
Shaw LJ, Blankstein R, Bax JJ...Cury R, et al. (in press) Society of 
Cardiovascular Computed Tomography / North American Society of 
Cardiovascular Imaging e Expert Consensus Document on Coronary CT 
Imaging of Atherosclerotic Plaque.  J Cardiovasc Comput Tomogr   Find it 
here! 
Yagnik GP, Santos ED, Rothfeld AA, Uribe JW, Cohn TM (2021) Spanish 
translation and cross-language validation of the American Shoulder and 
Elbow Surgeons Standardized Shoulder Assessment Form.  J Shoulder 
Elbow Surg 30: 151-157.  Find it here! 
Don’t forget to check out the new issue of the Nursing & Health 
Sciences Research Journal.  Find it here! 
Photo by Henry Be on Unsplash 
Explore more publications from the 
Baptist Health Institutional Repository 
 
Center for Advanced Analytics 
Center for Research 
Christine E. Lynn Heart & Vascular 
Institute 
Christine E. Lynn Women's Health & 
Wellness Institute 
Eugene M. & Christine E. Lynn Cancer 
Institute 
Marcus Neuroscience Institute 
Miami Cancer Institute 
Miami Cardiac & Vascular Institute 
Miami Neuroscience Institute 
Miami Orthopedics & Sports Medicine 
Institute 
 
Did we miss your publication?  
Please send it to: 
library@baptisthealth.net 
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Tuesdays 12:00 to 1:00 pm 
Invite was sent out to Research Operations & 
Regulatory teams. Certificates provided. 
Because of the COVID-19 pandemic, we will be 
doing Zoom™ meetings only until further notice. 
Click here or go to baptisthealth.zoom.us  
Meeting ID: 958 8490 1869 
Password: 861787 
Date Topic 
Tuesday, January 12th Consent Best Practices 
Tuesday, February 9th Investigator Initiated Trials 
Tuesday, March 9th Study Startup 
Tuesday, April 13th Audit Preparation 
Tuesday, May 11th Clinical Trial Agreement (CTA) Basics 
Tuesday, June 8th Research Finance Basics 
Tuesday, July 13th Appraisal of Statistical Methods in Research by Emir Veledar, Ph.D. 
Tuesday, August 10th Principles of Good Clinical Practice 
Tuesday, September 14th Participant Safety 
Tuesday, October 12th Preventing Noncompliance 
Tuesday, November 9th Participant Recruitment 
Tuesday, December 14th Study Documentation 
by Nursing & Clinical Research Organizations 
UPCOMING CONFERENCES 
Onsemble—April 18-22, 2021, Phoenix, AZ 
https://conference.onsemble.net/ 
ACRP— May 14-17, 2021, Toronto, Canada 
https://acrpnet.org/event/acrp-2021-annual-conference/  
SOCRA—September 24-26, 2021, Denver, CO 
https://www.socra.org/annual-conference/future-annual-conference-dates/  
Nursing World Conference—October 18-21, 2021, Virtual 
https://nursingworldconference.com/  





To serve as a 
research hub for 
elevating care 
through discovery for 
the diverse 
community we serve 
by using a shared 




collaborative intellect.  
 
VISION 
In alignment with the 
strategic goals of 
Baptist Health South 
Florida, and within the 
context of a 
sustainable business 




knowledge with the 
goals of providing 
continued excellence 
in patient care for the 
diverse multicultural 
community of South 
Florida. 
Here at Research Compliance, we recognize the importance of 
communicating the most accurate and up-to-date information about 
trials offered at Baptist Health to our customers. As such, the Center 
for Research provides research teams guidance and assistance 
when registering clinical trials and reporting their results on 
ClinicalTrials.gov. “ClinicalTrials.gov is a Web-based resource that 
provides patients, their family members, health care professionals, 
researchers, and the public with easy access to information on 
publicly and privately supported clinical studies on a wide range of 
diseases and conditions.”
1
 Upon request, we will also provide quality 
checks (QCs) of any records prior to submitting them with the aim to 
reduce the number of revisions required. In addition, we also 
provide guidance regarding whether a study should be registered in 
ClinicalTrials.gov or not. All questions and/or requests may be 
submitted via email. Please register all BHSF clinical trials in 
ClinicalTrials.gov under the Institution name, BaptistHSF, to allow 
the institution’s administrators access to the 
records.  1 https://clinicaltrials.gov/ct2/help/for-patient 
Do you have any questions or topics you would 
like for us to cover regarding conflicts of interest, 
compliance review, or billing compliance process? 
If so, contact us directly for all Research 
Compliance matters! 
Heather Osorio, Research Compliance & Billing 
Administrator, ResearchCompliance@baptisthealth.net   
Research Compliance Corner 
To contribute to this newsletter, please contact Dr. Amy Starosciak at amyst@baptisthealth.net or x79546. 
UPCOMING IRB DATES 
BHSF IRB 
Full Board Committee Meeting: Tuesday, January 26th  
Submission Deadline for February Meeting: Monday, January 25th 
MCI IRB 
Full Board Committee Meeting: Monday,  February 1st  
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